Current Vascular Pharmacology
ISSN:1570-1611

Current Vascular Pharmacology

CURR VASC PHARMACOL
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:较慢,6-12周
新锐分区:医学4区
年发文量:43
影响因子:2.1
JCR分区:Q3

基本信息

《当代血管药理学》出版临床和研究综述/小型综述、原创研究文章、信件、辩论、药物临床试验研究和客座编辑期刊,以更新所有与血管疾病治疗有关的内容,弥合临床实践和正在进行的研究之间差距。血管疾病是西方国家最常见的死亡原因,其发病率在发展中国家呈上升趋势。因此,大量研究旨在建立急性血管事件的有效治疗方法。长期治疗也受到了相当大的关注(例如症状缓解)。此外,有效的预防,无论是初级还是次级,都得到了几项里程碑式试验结果的支持。血管疾病是一个复杂的领域,涉及初级保健医生和护士以及几个专业。后者包括心脏病学、血管和心胸外科、普通医学、放射学、临床药理学和神经病学(卒中单元)。
1570-1611SCIE/Scopus收录
2.1
2.3
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
3区
PERIPHERAL VASCULAR DISEASE 外周血管病
4区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:PERIPHERAL VASCULAR DISEASE
SCIE
Q3
53/98
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
222/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:PERIPHERAL VASCULAR DISEASE
SCIE
Q3
62/99
学科:PHARMACOLOGY & PHARMACY
SCIE
Q3
232/353
54
43
3%较易较慢,6-12周-医学-外周血管病
9.5%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
55.81%4.07%-
CiteScore:5.40
SJR:0.726
SNIP:0.661
学科类别分区排名百分位
大类:Medicine
小类:Cardiology and Cardiovascular Medicine
Q2
105 / 397
大类:Medicine
小类:Pharmacology
Q2
128 / 321

期刊高被引文献

Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180209113014
Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180515154555
Pleiotropic Effects of Statins: Untapped Potential for Statin Pharmacotherapy.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180723120608
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190507110519
Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180123111949
Cardiovascular Risk in Psoriasis: Current State of the Art.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161115666171116163816
Uncaria rhynchophylla and Its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190704092841
Microvascular complications of type 2 diabetes mellitus.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190502103733
Herbal Medicine for Slowing Aging and Aging-Associated Conditions: Efficacy, Mechanisms, and Safety.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190715121939
Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180206113755
Gender-specific, Lifestyle-related Factors and 10-year Cardiovascular Disease Risk; the ATTICA and GREECS Cohort Studies.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180608121720
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190503123911
Cardiovascular Disease in Spondyloarthritides
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190426164306
Genetic Variations and Subclinical Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180206112635
Maternal Dyslipidaemia in Pregnancy with Gestational Diabetes Mellitus: Possible Impact on Foetoplacental Vascular Function and Lipoproteins in the Neonatal Circulation.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161115666171116154247
Aortic Stenosis, Aortic Regurgitation and Arterial Hypertension.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180101165306
Diabetes and heart failure: Is it hyperglycemia or hyperinsulinemia?
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190408164326
Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190426162746
Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180108113825
Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190619143842
Clinical Presentation, Quality of Care, Risk Factors and Outcomes in Women with Acute ST-Elevation Myocardial Infarction (STEMI): An Observational Report from Six Middle Eastern Countries.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180315104820
Does Perioperative Hemoglobin A1c Level Affect the Incidence, Pattern and Mortality of Lower Extremity Amputation?
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180123112529
Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180209112351
Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180206111725
Non-Traditional Cardiovascular Risk Markers in the Era of Established Major Risk Factors and Multiple Guidelines.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180123112956
Treatment of Diabetic Cardiovascular Autonomic, peripheral and painful neuropathy. Focus on the treatment of Cardiovascular Autonomic Neuropathy with ACE inhibitors.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190521101342
Metabolic complications and kidney transplantation: focus on glycaemia and dyslipidaemia.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190619143005
Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190507112157
Renal Dysfunction Following Elective Endovascular Aortic Aneurysm Repair.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161115666171116163203
Galectin-3 and Arterial Stiffness in Patients with Heart Failure: A Pilot Study.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180703094919
Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180206110657
The Role of Percutaneous Coronary Intervention in the Treatment of Chronic Total Occlusions: Rationale and Review of the Literature.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180117100635
Antithrombotic Therapy in Lower Extremity Artery Disease.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190206230516
Menopause and its Cardiometabolic Consequences: Current Perspectives.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117999190228123237
Hypertriglyceridemia: An Infrequent, Difficult-to-Predict, Severe Metabolic and Vascular Problem Associated with Estrogen Administration.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190306102322
Use of Alternative Antiplatelet Agents for Clopidogrel Hypersensitivity.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180730100806
Arterial Stiffness, Cognitive Dysfunction, and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190415112953
Effects of Intensive Blood Pressure Control in Patients with Evident Cardiovascular Disease: An Investigation Using the SPRINT Study Data.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180305160116
Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180730100346
The Significance of Pain in Chronic Venous Disease and its Medical Treatment.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180209111826
The endothelial glycocalyx as a key mediator of albumin handling and the development of diabetic nephropathy.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161118666191224120242
Is Atherothromboaspiration a Possible Solution for the Prevention of No-Reflow Phenomenon in Acute Coronary Syndromes? Single Centre Experience and Review of the Literature.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180101150956
Statins and Elderly: From Clinical Trials to Daily Practice.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180628145723
Complementary and Alternative Medicine for the Treatment of Insomnia: An Overview of Scientific Evidence from 2008 to 2018.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190506111239
Statins: Pharmacokinetics, Pharmacodynamics and Cost-Effectiveness Analysis.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180706144824
Clopidogrel Desensitization: Background and Recommendations for Use of a Rapid (4 Hour) Protocol.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666181031101930
Mandatory Reporting of Coronary Artery Calcifications Incidentally Noted on Chest Multi-Detector Computed Tomography: A Multicentre Experience.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180117111856
Cardiovascular Disease in Antiphospholipid Syndrome.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161117666190830101341
Is there Sex-related Outcome Difference According to oral P2Y12 Inhibitors in Patients with Acute Coronary Syndromes? A Systematic Review and Meta-Analysis of 107,126 Patients.
来源期刊:Current vascular pharmacologyDOI:10.2174/1570161116666180123092054
What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis?
来源期刊:Current vascular pharmacologyDOI:10.2174/157016111705190703102816

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
3区
PERIPHERAL VASCULAR DISEASE 外周血管病
4区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
PHARMACOLOGY & PHARMACY 药学
3区
PERIPHERAL VASCULAR DISEASE 外周血管病
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
PERIPHERAL VASCULAR DISEASE 外周血管病
3区
PHARMACOLOGY & PHARMACY 药学
3区